title: Enhanced surveillance of primary measles mumps and rubella (MMR) immunisation in Wales.
abstract: In England and Wales routinely available data measure uptake of the measles mumps and rubella (MMR) vaccine at 2 years. This results in a delay in detecting change in uptake of the vaccine, which is scheduled at 12 months of age. The predictive value of uptake at 15-17 months is limited by the greater variability in uptake between quarters at the younger age. This can be overcome by presenting the data as a four-quarter annual rolling average. Uptake of the MMR vaccine at 2 years of age in Wales is predicted to stabilise at around 84% in the first three quarters of 2002.
authors.affiliation: Public Health Laboratory Service, Communicable Disease Surveillance Centre (Wales), Abton House, Wedal Road, CF14 3QX, Cardiff, UK. brendan.mason@phls.wales.nhs.uk
authors.forename: Brendan W
authors.initials: BW
authors.lastname: Mason
authors.forename: Daniel R h
authors.initials: DR
authors.lastname: Thomas
authors.forename: Roland L
authors.initials: RL
authors.lastname: Salmon
mesh_terms: D002675:Child, Preschool; D006801:Humans; D017589:Immunization Programs / Q000379:methods* / Q000706:statistics & numerical data* / Q000600:supply & distribution; D007115:Immunization Schedule; D007223:Infant; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage*; D011159:Population Surveillance / Q000379:methods*; D011237:Predictive Value of Tests; D011446:Prospective Studies
chemical_list: D022542:Measles-Mumps-Rubella Vaccine